Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PLA2G6 | O60733 | 2/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9618689 | 0.86 | HPGD (0.43) | CA2POLBESR2PARP1HPGD | |
| SCHEMBL27816269 | 0.85 | GRM2 (0.44) | CA2HPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL15111194 | 0.83 | GRM2 (0.45) | HPGDCYP1A2KMT2AMEN1ALDH1A1 | |
| SCHEMBL3763119 | 0.80 | CA2 (0.45) | CA2POLBESR2PARP1HPGD | |
| SCHEMBL2475144 | 0.77 | PLA2G6 (0.36) | ESR2CYP1A2CYP2C19PLA2G6PLA2G4A | |
| SCHEMBL407486 | 0.76 | CA2 (0.47) | CA2PARP1HTT | |
| SCHEMBL1689230 | 0.76 | CA2 (0.42) | CA2POLBPARP1SMN1; SMN2HTT | |
| SCHEMBL8098626 | 0.76 | CA2 (0.42) | CA2POLBPARP1KMT2AMEN1 | |
| SCHEMBL6272291 | 0.76 | CA2 (0.42) | CA2POLBPARP1HPGDSMN1; SMN2 | |
| SCHEMBL17818421 | 0.76 | ESR1 (0.47) | ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9364511-B2 | Antiviral preparations obtained from a natural cinnamon extract | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2016-06-14 | — | — | US | disclosed |
| EP-1711192-B1 | ANTIVIRAL PREPARATIONS OBTAINED FROM A NATURAL CINNAMON EXTRACT | UNIV RAMOT (IL) | 2013-12-04 | — | — | EP | disclosed |
| EP-2422805-A1 | Antiviral preparations obtained from a natural cinnamon extract | Ramot at Tel-Aviv University Ltd. (IL) | 2012-02-29 | — | — | EP | disclosed |
| CN-1897958-B | Antiviral preparations obtained from a natural cinnamon extract | UNIV RAMOT | 2011-02-02 | — | — | CN | disclosed |
| US-20090209605-A1 | NEMATICIDAL COMPOSITIONS | DEVGEN N.V. (BE) | 2009-08-20 | — | — | US | disclosed |
| US-7390804-B2 | N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-06-24 | — | — | US | disclosed |
| US-7390804-B2 | N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-06-24 | — | — | US | disclosed |
| US-20080146445-A1 | Nematicidal Compositions | DEVGEN NV (BE) | 2008-06-19 | — | — | US | disclosed |
| CN-1897958-A | Antiviral preparations obtained from a natural cinnamon extract | UNIV RAMOT (IL) | 2007-01-17 | — | — | CN | disclosed |
| US-20060275515-A1 | Antiviral preparations obtained from a natural cinnamon extract | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2006-12-07 | — | — | US | disclosed |
| EP-1165557-A1 | ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS | NEUROGEN CORPORATION (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000059905-A1 | ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS | NEUROGEN CORPORATION (US) | 2000-10-12 | — | — | WO | disclosed |
| US-4540800-A | FROM CATECHOL, ALDEHYDE OR ALLYL ALCOHOL, SOLID ACID CATALYST | UBE INDUSTRIES, LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209605-A1 | NEMATICIDAL COMPOSITIONS | ACHE, DNPH1, NANP | CA2 3555/4885POLB 3743/4885ESR2 4630/4885 |
| US-20080146445-A1 | Nematicidal Compositions | ACHE, DNPH1, NANP | CA2 3555/4885POLB 3743/4885ESR2 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.